For many human tumors, eEF1A2 is a putative oncogene because of its ectopic expression, that relates with tumor onset as firstly demonstrated in 2002, when Anand et al. found expression of eEF1A2 in 30% of ovarian tumors, but not in normal ovary cells [29]. This evidence concerns the gene EEF1A2 and ovarian neoplasm.